Table 2.
Correlations between engraftment rate and clinicopathological characteristics of all patients
| Clinicopathological characteristics | No. of patients(%) | Successful engraftment (%) | P-value |
|---|---|---|---|
| Gender | 0.412 | ||
| Male | 34 (60.7%) | 17 (50.0%) | |
| Female | 22 (39.3%) | 8 (36.4%) | |
| Age | 0.591 | ||
| ≥55 | 28 (50.0%) | 14 (50.0%) | |
| <55 | 28 (50.0%) | 11 (39.3%) | |
| Tumor type | 0.013* | ||
| WDLPS | 16 (28.5%) | 3 (18.8%) | |
| DDLPS | 35 (62.5%) | 17 (48.6%) | |
| MLPS | 2 (3.6%) | 2 (100.0%) | |
| PLS | 3 (5.4%) | 3 (100.0%) | |
| Tumor volume (cm3) | >0.999 | ||
| ≥1000 | 35 (62.5%) | 16 (45.7%) | |
| <1000 | 21 (37.5%) | 9 (42.9%) | |
| Grade | 0.001** | ||
| 1 | 12 (24.0%) | 3 (25.0%) | |
| 2 | 18 (36.0%) | 5 (27.8%) | |
| 3 | 20 (40.0%) | 16 (80.0%) | |
| Vascular invasion | 0.462 | ||
| Yes | 1 (2.6%) | 1 (100%) | |
| No | 38 (97.4%) | 17 (44.7%) | |
| Lymph node metastasis | >0.999 | ||
| Yes | 2 (4.5%) | 1 (50.0%) | |
| No | 42 (95.5%) | 20 (47.6%) | |
| Organ invasion | 0.048* | ||
| Yes | 36 (64.3%) | 20 (55.6%) | |
| No | 20 (35.7%) | 5 (25.0%) | |
| Primary/recurrence | 0.591 | ||
| Primary | 28 (50%) | 11 (39.3%) | |
| Recurrence | 28 (50%) | 14 (50%) | |
| Distant metastasis | >0.999 | ||
| Yes | 3 (7.7%) | 1 (33.3%) | |
| No | 36 (92.3%) | 17 (47.2%) |